Abstract Context The European Association of Urology (EAU) has released an updated
version of the guidelines on non–muscle-invasive bladder cancer (NMIBC). Objective To …

This Seminar presents the current best practice for the diagnosis and management of
bladder cancer. The scope of this Seminar ranges from current challenges in pathology …

Non-muscle-invasive bladder cancer (NMIBC) is an early-stage cancer without invasion into
the detrusor muscle layer. Transurethral resection of bladder tumour (TURBT) is a diagnostic …

Context Transurethral resection of bladder tumour (TURBT) for bladder cancer (BC) is an
underappreciated common urological procedure. TURBT outcomes are highly variable, and …

Objective To update the ccAFU recommendations for the management of bladder tumours
that do not infiltrate the bladder muscle (NBMIC). Methods A systematic review (Medline) of …

Résumé Objectif.-Actualiser les recommandations du Comité de cancérologie de
l'Association française d'urologie (CCAFU) pour la prise en charge des tumeurs de la vessie …

Bladder cancer is the fifth most common cancer worldwide. 1 In Canada, the estimated
incidence for 2020 was of 12 200 new cases, with 2600 disease-related deaths during that …

Transurethral resection of bladder tumor (TURBT) is still the gold standard for the diagnosis,
treatment, and staging of nonmuscle invasive bladder cancer. En bloc resection of bladder …

1.1 Aim and scope This overview represents the updated European Association of Urology
(EAU) Guidelines for Non-muscleinvasive Bladder Cancer (NMIBC), TaT1 and carcinoma in …

Aim Bladder cancer (BLCA) is an urogenital system tumor with a high morbidity. We aimed
to explore the function and potential mechanism of α-E-catenin (CTNNA1) in BLCA. Methods …